Ono Pharmaceutical Co., Ltd.
OPHLY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $205 | $166 | $96 | $69 |
| Short-Term Investments | $6 | $38 | $68 | $48 |
| Receivables | $135 | $136 | $114 | $100 |
| Inventory | $75 | $49 | $45 | $42 |
| Other Curr. Assets | $35 | $24 | $22 | $23 |
| Total Curr. Assets | $455 | $414 | $345 | $281 |
| Property Plant & Equip (Net) | $106 | $105 | $108 | $112 |
| Goodwill | $21 | $0 | $0 | $0 |
| Intangibles | $330 | $57 | $69 | $65 |
| Long-Term Investments | $89 | $297 | $324 | $2 |
| Tax Assets | $51 | $0 | $36 | $25 |
| Other NC Assets | $12 | $41 | $0 | $254 |
| Total NC Assets | $609 | $500 | $537 | $458 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,064 | $914 | $882 | $739 |
| Liabilities | – | – | – | – |
| Payables | $89 | $61 | $67 | $50 |
| Short-Term Debt | $33 | $2 | $3 | $2 |
| Tax Payable | $4 | $22 | $35 | $2 |
| Deferred Revenue | $0 | $0 | $35 | $2 |
| Other Curr. Liab. | $22 | $19 | -$16 | $10 |
| Total Curr. Liab. | $148 | $104 | $123 | $66 |
| LT Debt | $114 | $7 | $7 | $7 |
| Deferred Rev, NC | $0 | $0 | $3 | $3 |
| Deferred Tax Liab, NC | $11 | $1 | $0 | $0 |
| Other NC Liab. | $3 | $4 | $2 | $2 |
| Total NC Liab. | $128 | $11 | $12 | $12 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $9 | $9 | $9 |
| Total Liabilities | $276 | $115 | $135 | $78 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17 | $17 | $17 | $17 |
| Retained Earnings | $791 | $768 | $710 | $645 |
| AOCI | $20 | $53 | $52 | $51 |
| Other Equity | -$46 | -$46 | -$37 | -$57 |
| Total Equity | $782 | $793 | $742 | $656 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $6 | $6 | $6 | $6 |
| Total Liab. & Tot. Equity | $1,064 | $914 | $882 | $739 |
| Net Debt | -$58 | -$157 | -$87 | -$60 |